Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 6/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | CTSB | P07858 | 3/20 | 0.45 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.45 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.45 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9069779 | 0.87 | PPARG (0.47) | CTSLMEN1KMT2ACTSBITGA4 | |
| SCHEMBL7328473 | 0.86 | HTR2A (0.53) | CTSLMEN1KMT2AHTR2ACTSB | |
| SCHEMBL7333604 | 0.86 | HTR2A (0.53) | CTSLMEN1KMT2AHTR2ACTSB | |
| SCHEMBL2747548 | 0.86 | MEN1 (0.50) | MEN1KMT2ANPC1TP53RAB9A | |
| SCHEMBL7327394 | 0.85 | CTSL (0.57) | P2RX7CTSLMEN1KMT2ACTSB | |
| SCHEMBL1715348 | 0.85 | CTSL (0.57) | P2RX7CTSLMEN1KMT2ACTSB | |
| SCHEMBL10793551 | 0.85 | CTSL (0.57) | P2RX7CTSLMEN1KMT2ACTSB | |
| SCHEMBL11771667 | 0.83 | CTSL (0.55) | CTSLMEN1KMT2AHTR2ACTSB | |
| SCHEMBL7278892 | 0.83 | CTSL (0.55) | CTSLMEN1KMT2AHTR2ACTSB | |
| SCHEMBL7278888 | 0.83 | CTSL (0.55) | CTSLMEN1KMT2AHTR2ACTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5212287-A | Multistage synthesis of oligopeptides with protection of side groups then deprotection after reaction | IMMUNETECH PHARMACEUTICALS, INC. (US) | 1993-05-18 | — | — | US | claimed |
| US-5212287-A | Multistage synthesis of oligopeptides with protection of side groups then deprotection after reaction | IMMUNETECH PHARMACEUTICALS, INC. (US) | 1993-05-18 | — | — | US | disclosed |
| US-3971822-A | Aspartyl amide sweetening agents | TANABE SEIYAKU CO., LTD. (JA) | 1976-07-27 | — | — | US | disclosed |